Leap Therapeutics Investor Relations Material
Latest events
Status Update
Leap Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Leap Therapeutics Inc
Access all reports
Leap Therapeutics Inc. is a clinical-stage biopharmaceutical company that focuses on developing novel therapeutics for cancer treatment. The company's main activities involve acquiring and developing antibody therapies, particularly targeting cancer-specific pathways and cell surface molecules, while also activating the immune system against cancer cells. Leap Therapeutics is engaged in multiple ongoing clinical trials for its lead product candidates. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Leap Therapeutics Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Leap Therapeutics Inc
Study Result
Leap Therapeutics Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
LPTX
Country
🇺🇸 United States